Cra Financial Services, LLC Bristol Myers Squibb CO Transaction History

Cra Financial Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	SELL	$72.62 - $79.98 $217,424 - $239,460	-2,994 Closed	0 $0
Q1 2022 Apr 15, 2022	SELL	$61.48 - $73.72 $31,846 - $38,186	-518 Reduced 14.75%	2,994 $219,000
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $7,990 - $9,315	-149 Reduced 4.07%	3,512 $219,000
Q3 2021 Oct 12, 2021	BUY	$59.17 - $69.31 $177 - $207	3 Added 0.08%	3,661 $217,000
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $9,410 - $10,247	152 Added 4.34%	3,658 $244,000
Q1 2021 Apr 16, 2021	BUY	$59.34 - $66.74 $208,046 - $233,990	3,506 New	3,506 $221,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Cra Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Cra Financial Services, LLC with notifications on news.